MCM
MRK icon

Mengis Capital Management’s Merck MRK Stock Holding History

Mengis Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.88M Sell
48,922
-2,174
-4% -$251K 1.01% 23
2025
Q4 		$5.38M Sell
51,096
-799
-2% -$75K 0.95% 26
2025
Q3 		$4.36M Sell
51,895
-4,398
-8% -$362K 0.86% 30
2025
Q2 		$4.46M Sell
56,293
-11,576
-17% -$920K 0.95% 27
2025
Q1 		$6.09M Sell
67,869
-39,320
-37% -$3.67M 1.27% 18
2024
Q4 		$10.7M Sell
107,189
-3,326
-3% -$343K 2.18% 11
2024
Q3 		$12.6M Sell
110,515
-1,230
-1% -$146K 2.47% 6
2024
Q2 		$13.8M Sell
111,745
-14,859
-12% -$1.91M 2.8% 6
2024
Q1 		$16.7M Buy
126,604
+3,553
+3% +$438K 2.58% 5
2023
Q4 		$13.4M Sell
123,051
-747
-0.6% -$77.5K 2.51% 6
2023
Q3 		$12.7M Sell
123,798
-577
-0.5% -$62.2K 2.65% 6
2023
Q2 		$14.4M Sell
124,375
-4,910
-4% -$557K 2.86% 4
2023
Q1 		$13.8M Sell
129,285
-11,648
-8% -$1.26M 2.9% 4
2022
Q4 		$15.6M Sell
140,933
-4,579
-3% -$468K 3.41% 4
2022
Q3 		$12.5M Sell
145,512
-6,654
-4% -$594K 2.97% 5
2022
Q2 		$13.9M Sell
152,166
-1,340
-0.9% -$119K 3.05% 4
2022
Q1 		$12.6M Buy
153,506
+160
+0.1% +$12.6K 2.41% 6
2021
Q4 		$11.8M Buy
153,346
+7,012
+5% +$558K 2.21% 7
2021
Q3 		$11M Buy
146,334
+1,609
+1% +$122K 2.31% 6
2021
Q2 		$11.3M Buy
144,725
+11,347
+9% +$844K 2.33% 7
2021
Q1 		$9.81M Buy
133,378
+9,583
+8% +$707K 2.17% 7
2020
Q4 		$9.66M Buy
123,795
+15,183
+14% +$1.16M 2.35% 5
2020
Q3 		$8.6M Buy
108,612
+7,934
+8% +$621K 2.36% 5
2020
Q2 		$7.43M Buy
100,678
+7,168
+8% +$540K 2.21% 7
2020
Q1 		$6.87M Buy
93,510
+14,923
+19% +$1.17M 2.35% 7
2019
Q4 		$6.82M Buy
78,587
+9,070
+13% +$745K 1.88% 10
2019
Q3 		$5.58M Buy
69,517
+2,047
+3% +$164K 1.66% 12
2019
Q2 		$5.4M Buy
67,470
+3,541
+6% +$271K 1.65% 15
2019
Q1 		$5.07M Buy
63,929
+3,478
+6% +$260K 2.83% 7
2018
Q4 		$4.41M Sell
60,451
-782
-1% -$55.2K 2.79% 7
2018
Q3 		$4.14M Buy
61,233
+215
+0.4% +$13.7K 2.28% 9
2018
Q2 		$3.53M Buy
61,018
+833
+1% +$47K 2.09% 13
2018
Q1 		$3.13M Buy
60,185
+1,734
+3% +$93.6K 1.87% 14
2017
Q4 		$3.14M Buy
58,451
+6,925
+13% +$384K 1.9% 14
2017
Q3 		$3.15M Buy
51,526
+681
+1% +$41.3K 2.11% 14
2017
Q2 		$3.11M Buy
50,845
+1,499
+3% +$91.2K 2.2% 12
2017
Q1 		$2.99M Buy
49,346
+1,729
+4% +$105K 2.19% 12
2016
Q4 		$2.67M Buy
47,617
+12,006
+34% +$703K 2.13% 15
2016
Q3 		$2.12M Buy
35,611
+734
+2% +$42.9K 1.76% 18
2016
Q2 		$1.92M Buy
34,877
+12,471
+56% +$664K 1.69% 21
2016
Q1 		$1.13M Buy
22,406
+4,042
+22% +$198K 1.04% 34
2015
Q4 		$925K Buy
18,364
+13,284
+261% +$670K 0.81% 38
2015
Q3 		$239K Buy
5,080
+525
+12% +$27.9K 0.22% 91
2015
Q2 		$247K Buy
4,555
+1
+0% +$56 0.21% 93
2015
Q1 		$249K Buy
4,554
+1
+0% +$57 0.22% 95
2014
Q4 		$246K Buy
+4,553
New +$254K 0.24% 92

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mengis Capital Management's MRK Position: Q1 2026 in Review

Mengis Capital Management reduced its Merck (MRK) stake by 4.3% in Q1 2026, selling an estimated $251K and leaving 48,922 shares worth $5.88M. The position accounts for 1.01% of the portfolio, ranked #23.

Mengis Capital Management first reported a position in MRK in Q4 2014 and has held it in 46 quarters since. The position peaked at $16.7M in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Mengis Capital Management held 48,922 shares of Merck worth $5.88M as of Q1 2026.
  • Mengis Capital Management sold 2,174 Merck shares in Q1 2026, an estimated $251K.
  • Merck made up 1.01% of Mengis Capital Management's portfolio in Q1 2026, its #23 holding.
  • Mengis Capital Management first reported a position in Merck in Q4 2014 and has held it in 46 quarters since.
  • Mengis Capital Management's Merck position peaked at $16.7M in Q1 2024.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Mengis Capital Management's 13F filing for Q1 2026, filed 12 May 2026.